Abstract
Two recent observational studies1,2 and associated articles in the press3,4 have raised concerns about the potential risks associated with prescription of testosterone to older men. However, these concerns are not new and are reminiscent of the debate about hormone replacement therapy and heart disease in women that raged before the Women's Health Initiative. However, if one thing was learnt from the Women's Health Initiative, it is that cumulative observational data cannot replace well-designed and undertaken randomised clinical trials.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.